You have 9 free searches left this month | for more free features.

Alpha Linolenic Acid

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Weight Trajectory Trial in San Francisco (gamma-linolenic acid, )

Active, not recruiting
  • Weight Trajectory
  • gamma-linolenic acid
  • placebo
  • San Francisco, California
    Virta Health
Mar 29, 2021

Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

Recruiting
  • Depressive Disorder, Major
  • +2 more
  • New Haven, Connecticut
    Yale University
Aug 8, 2022

No-Reflow Phenomenon Trial (Alpha Lipoic Acid plus the standard care for post-PCI MI, The standard care for post-PCI MI)

Not yet recruiting
  • No-Reflow Phenomenon
  • Alpha Lipoic Acid plus the standard care for post-PCI MI
  • The standard care for post-PCI MI
  • (no location specified)
Apr 29, 2022

Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)

Completed
  • Diabetic Neuropathies
  • +2 more
  • Epineuron
  • Placebo group
  • Thessaloníki, Thessaloniki, Greece
    University General Hospital AHEPA
Aug 8, 2023

Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500

Recruiting
  • Pancreas Adenocarcinoma
  • CPI-613® (Dose level -1.0 250 mg/m^2)
  • +6 more
  • Detroit, Michigan
  • +1 more
Nov 9, 2022

Diabetes, Type 2 Trial in Nashville (L-Lysine, Normal Saline)

Enrolling by invitation
  • Diabetes Mellitus, Type 2
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Mar 11, 2022

Pompe Disease Infantile-Onset Trial in China (GC301)

Not yet recruiting
  • Pompe Disease Infantile-Onset
  • GC301
  • Beijing, China
  • +4 more
Apr 2, 2023

Antioxidative Stress, End Stage Renal Disease on Dialysis Trial in Cairo (Alpha lipoic acid, Selenium)

Completed
  • Antioxidative Stress
  • End Stage Renal Disease on Dialysis
  • Cairo, Egypt
    Ain Shams University
Mar 1, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Iowa City (BodyBio Balance Oil, Kirunal Fish Oil, BodyBio PC)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • BodyBio Balance Oil
  • +5 more
  • Iowa City, Iowa
    Univeristy of Iowa
Jun 30, 2022

Breast Cancer, Chemotherapeutic Toxicity Trial in Tanta (Alpha-lipoic acid Plus Chemotherapy (doxorubicin (also known as

Completed
  • Breast Cancer
  • Chemotherapeutic Toxicity
  • Alpha-lipoic acid Plus Chemotherapy (doxorubicin (also known as Adriamycin) plus cyclophosphamide followed by taxol)
  • Placebo Plus Chemotherapy (doxorubicin (also known as Adriamycin) plus cyclophosphamide followed by taxol)
  • Tanta, Gharbia, Egypt
    Tanta Oncology Center
Oct 4, 2021

Healthy Trial (200mg GCE +200mg ALA, 200mg GCE +400mg ALA, 200mg GCE + 200mg DHB)

Not yet recruiting
  • Healthy
  • 200mg GCE +200mg ALA
  • +3 more
  • (no location specified)
Nov 13, 2023

Burning Mouth Syndrome Trial (drug, other, dietary supplement, radiation)

Not yet recruiting
  • Burning Mouth Syndrome
  • topical placebo tablet
  • +5 more
  • (no location specified)
Sep 10, 2023

Infantile-onset Pompe Disease Trial in Beijing (Genetic: GC301)

Recruiting
  • Infantile-onset Pompe Disease
  • Genetic: GC301
  • Beijing, Beijing, China
    Bayi Children's Hospital, Seventh Medical Center, PLA general ho
Sep 30, 2022

Healthy Trial (alpha-linolenic acid-rich supplement)

Completed
  • Healthy
  • alpha-linolenic acid-rich supplement
  • (no location specified)
Feb 11, 2019

Child Obesity Trial in Verona (wNUTS, low-caloric diet plus nuts, w/oNUTS, low-caloric diet without nuts)

Terminated
  • Child Obesity
  • wNUTS, low-caloric diet plus nuts
  • w/oNUTS, low-caloric diet without nuts
  • Verona, VR, Italy
    AOUI Verona
May 18, 2022

Adolescent Migraine Trial in Bhubaneswar (Flunarizine 5mg, Alpha lipoic acid 300mg)

Recruiting
  • Adolescent Migraine
  • Flunarizine 5mg
  • Alpha lipoic acid 300mg
  • Bhubaneswar, Odisha, India
    AIIMS
Oct 26, 2021

Mucositis (MeSH Unique ID: D052016), Stomatitis (MeSH Unique ID: D013280) Trial (1. alpha acid lipoic - tables, 2. ozonated oil

Not yet recruiting
  • Mucositis (MeSH Unique ID: D052016)
  • Stomatitis (MeSH Unique ID: D013280)
  • 1. alpha acid lipoic - tables
  • +3 more
  • (no location specified)
Jan 26, 2022

Asthma Trial in Pittsburgh (Conjugated Linolenic Acid, Sodium Nitrite, Sodium Nitrate)

Completed
  • Asthma
  • Conjugated Linolenic Acid
  • +2 more
  • Pittsburgh, Pennsylvania
    The University of Pittsburgh Asthma Institute at UPMC
Apr 5, 2021

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Healthy Trial in Nashville (Lysine, Controlled Diet)

Enrolling by invitation
  • Healthy
  • Lysine
  • Controlled Diet
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Sep 27, 2021

Cystinuria Trial in San Francisco (Alpha lipoic acid, Placebo)

Active, not recruiting
  • Cystinuria
  • Alpha lipoic acid
  • Placebo
  • San Francisco, California
    University of California, San Francisco
Aug 31, 2021

Multiple Sclerosis Trial in Canada, United States (Lipoic acid, Placebo)

Active, not recruiting
  • Multiple Sclerosis
  • Lipoic acid
  • Placebo
  • Birmingham, Alabama
  • +10 more
Jan 31, 2023

Radiation-Induced Mucositis Trial in Cairo (drug, other, radiation)

Not yet recruiting
  • Radiation-Induced Mucositis
  • Alpha Lipoic Acid 600 MG Oral Tablets
  • +2 more
  • Cairo, Egypt
    Ain Shams University
Aug 20, 2021

Epilepsy Trial in Palo Alto (Vinpocetine)

Suspended
  • Epilepsy
  • Palo Alto, California
    Stanford University
Jul 7, 2022

COVID-19 Trial in Orange (NAC (N-acetyl cysteine) , Alpha lipoic acid (ALA), liposomal glutathione (GSH))

Not yet recruiting
  • COVID-19
  • NAC (N-acetyl cysteine) , Alpha lipoic acid (ALA), liposomal glutathione (GSH)
  • Orange, California
    University of California Irvine Medical Center
May 10, 2022